Study ID | Intervention(s) and comparator(s) | Participants included in analysis (N) | Participants discontinuing trial due to an adverse event (N) | Participants discontinuing trial due to an adverse event (%) |
Duncan 2018 | I: hyperinsulinaemic normoglycaemia | 226* | 0* | 0* |
C: standard therapy | 249* | 0* | 0* | |
Wallia 2017 | I: intensive | 23* | 0* | 0* |
C: moderate | 26* | 0* | 0* | |
Wahby 2016 | I: tight glycaemic control | 67 | 0 | 0 |
C: conventional moderate glycaemic control | 68 | 0 | 0 | |
Parekh 2016 | I: moderately intense control | 30 | 0 | 0 |
C: standard glucose control | 30 | 0 | 0 | |
Yuan 2015 | I: intensive glycaemic management | 106 | 0 | 0 |
C: conventional glycaemic management | 106 | 0 | 0 | |
Umpierrez 2015 | I: intensive group | 77* | 0* | 0* |
C: conservative control | 75* | 0* | 0* | |
Abdelmalak 2013 | I: intensive glucose management | 54* | 0* | 0* |
C: conventional glucose management | 49* | 0* | 0* | |
Hermayer 2012 | I: intensive glycaemic control | 44 | — | — |
C: standard glycaemic control | 49 | — | — | |
Desai 2012 | I: strict blood glucose control | 37* | — | — |
C: liberal blood glucose control | 44* | — | — | |
Lazar 2011 | I: aggressive glucose control | 40 | 0 | 0 |
C: moderate glucose control | 42 | 0 | 0 | |
Cao 2010 | I: intensive insulin therapy | 92 | — | — |
C: conventional insulin therapy | 87 | — | — | |
Glucontrol 2009 | I: intensive insulin treatment | 55* | — | — |
C: intermediate glucose control | 69* | — | — | |
NICE SUGAR 2009 | I: intensive insulin therapy | 3054a | 304a | 10a |
C: conventional insulin therapy | 3050a | 225a | 7.4a | |
Subramaniam 2009 | I: continuous insulin infusion | 62* | 0* | 0* |
C: standard intermittent sliding‐scale insulin bolus | 64* | 0* | 0* | |
Chan 2009 | I: intensive insulin therapy | 55a | 7a | 12.7a |
C: conventional insulin therapy | 54a | 4a | 7.4a | |
De La Rosa 2008 | I: intensive insulin therapy | 254a | 0a | 0a |
C: conventional insulin therapy | 250a | 0a | 0a | |
Gandhi 2007 | I: intensive insulin therapy | 37 | 0 | 0 |
C: conventional insulin therapy | 36 | 0 | 0 | |
Li 2006 | I: continuous insulin infusion | 51 | — | — |
C: glucometer‐guided insulin | 42 | — | — | |
Lazar 2004 | I: tight glycaemic control with GIK | 72 | 0 | 0 |
C: standard therapy | 69 | 0 | 0 | |
Rassias 1999 | I: aggressive insulin therapy | 13 | 0 | 0 |
C: standard insulin therapy | 13 | 0 | 0 | |
—: denotes not reported adata from total study population. *data provided by study authors (patients with diabetes). C: comparator; I: intervention; GIK: glucose‐insulin‐potassium. |